VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has moved its VXA-222 bispecific antibody-drug conjugate program into the next stage of development after completing the initial phase of its collaboration with OmniAb, giving the biotechnology company a new development milestone while it continues expanding the intellectual-property estate underpinning its antibody technology […]

The Strait of Hormuz closure that began in late February 2026 removed more than 11 million barrels of Middle Eastern crude per day from global markets and sent Brent crude from roughly $62 a barrel in December 2025 to more than $117 by April 2026. Diesel and jet fuel wholesale prices are forecast to rise […]

Public safety agencies are increasingly confronting a technology environment in which detection, response, training and digital evidence must work together rather than operate as isolated systems. As agencies modernize their operations, the opportunity is expanding beyond individual products toward connected platforms capable of supporting multiple stages of the public safety workflow. Wrap Technologies (NASDAQ: WRAP) […]

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Modern militaries have built decades of doctrine around the assumption that satellite navigation would remain available when needed, but that assumption is increasingly being challenged in real-world operations. Drone operators can have clear video feed while the coordinates associated […]

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is advancing its oncology pipeline with a strategy centered on changing how antibody-based therapies recognize and attack cancer cells. The biotechnology company is developing bispecific antibody-drug conjugates, T-cell engagers and other engineered antibody formats, with its proprietary BiTAC technology providing the distinctive element […]

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is strengthening its corporate and commercial capabilities with two senior appointments as the company advances development of its Texatron(TM) Fusion Engine(TM). On Aug. 10, the company appointed John Gerdin to its Board of Directors as an independent director and strategic advisor, followed two days […]

U.S. manufacturing is in the middle of a reshoring wave. Companies are moving production back to the United States, driven by supply chain resilience needs, CHIPS Act-adjacent demand and a broader push to reduce reliance on China. According to the Reshoring Initiative’s 2024 Annual Report, more than 2 million manufacturing jobs have been announced in […]

Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, recently acquired Meduvo LLC, a compounding pharmacy. Meduvo currently operates from a 2,000-square-foot facility in La Verne, California, where it compounds and dispenses non-sterile medications. The acquisition expands the company’s already wide network to 34 jurisdictions in the United […]

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is expanding its scientific team and intellectual property portfolio as it moves its Texatron(TM) Fusion Engine(TM) program into a more active testing phase. The company recently appointed Dr. Noah D’Amico, a physicist and engineer at Texas Tech University, as a Strategic Advisor (https://ibn.fm/WSxwY). The […]

Multiple sclerosis (“MS”) treatment has traditionally focused on controlling the immune activity that drives new inflammatory lesions and relapses. While this approach has transformed the management of relapsing MS, growing attention is being directed toward another fundamental challenge: protecting the nervous system from the damage that can accumulate over time and contribute to disability progression.  […]